XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2.100
+0.100 (5.00%)
Jul 14, 2026, 5:24 PM IDT

XTL Biopharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.080.371.42.092.97
Trading Asset Securities
-0.770.611.633.16
Cash & Short-Term Investments
0.081.142.013.726.13
Cash Growth
-93.35%-43.02%-46.09%-39.27%1.41%
Accounts Receivable
-0.1---
Receivables
-0.1---
Prepaid Expenses
-0.050.030.070.09
Other Current Assets
0.090.050.010.010.02
Total Current Assets
0.171.342.053.816.24
Property, Plant & Equipment
-0.19--0
Goodwill
-3.19---
Other Intangible Assets
-3.820.380.380.38
Other Long-Term Assets
-0.01---
Total Assets
0.178.552.434.196.62
Accounts Payable
0.020.23000
Accrued Expenses
0.130.550.210.190.23
Short-Term Debt
-0.14---
Current Unearned Revenue
-0.02---
Other Current Liabilities
0.271.28---
Total Current Liabilities
0.422.210.210.190.23
Long-Term Deferred Tax Liabilities
-0.22---
Other Long-Term Liabilities
-0.69--1.05
Total Liabilities
0.423.120.210.191.29
Common Stock
25.1423.1414.1214.1214.12
Additional Paid-In Capital
140.22141.29146.33146.33146.33
Retained Earnings
-165.63-159.01-158.25-156.47-155.13
Comprehensive Income & Other
0.020.020.020.020.02
Shareholders' Equity
-0.255.442.2245.33
Total Liabilities & Equity
0.178.552.434.196.62
Total Debt
-0.14---
Net Cash (Debt)
0.081.012.013.726.13
Net Cash Growth
-92.44%-49.90%-46.09%-39.27%1.41%
Net Cash Per Share
0.000.000.000.010.01
Filing Date Shares Outstanding
982.99881.39544.91544.91544.91
Total Common Shares Outstanding
946.24881.39544.91544.91544.91
Working Capital
-0.25-0.871.843.626.01
Book Value Per Share
-0.000.010.000.010.01
Tangible Book Value
-0.25-1.571.843.624.95
Tangible Book Value Per Share
-0.00-0.000.000.010.01